TY  - JOUR

T1  - Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19

JO  - Immunology

UR  - http://dx.doi.org/10.1111/imm.13585

PY  - 2022/11/28

AU  - Siggins MK

AU  - Davies K

AU  - Fellows R

AU  - Thwaites RS

AU  - Baillie JK

AU  - Semple MG

AU  - Openshaw PJM

AU  - Zelek WM

AU  - Harris CL

AU  - Morgan BP

ED  - 

DO  - DOI: 10.1111/imm.13585

PB  - Wiley

VL  - 168

IS  - 3

SP  - 473

EP  - 492

Y2  - 2024/12/22

ER  -